ImaginAb AB, based in Inglewood, CA, is a pioneering biotech company specializing in innovative imaging and radiopharmaceutical therapy solutions for immuno-oncology. Their advanced CD8 ImmunoPET technology provides detailed immune status profiles for patients undergoing treatment, while their radiopharmaceutical therapy products aim to target and eliminate tumor cells with precision.
With a focus on challenging the status quo, creating cutting-edge solutions, and transforming patient care paths, ImaginAb is at the forefront of revolutionizing immuno-oncology. Their team of experts is dedicated to reimagining the future of cancer care through medical expertise and scientific innovation, driving progress in the field of immunotherapy.
Generated from the website